Core Scientific (CORZ) Net Income towards Common Stockholders (2020 - 2026)

Core Scientific (CORZ) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$347.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 160.25% year-over-year to -$347.2 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 13.03% YoY), and the FY2025 full-year result was -$288.6 million, up 79.93% from the prior year.
• Net Income towards Common Stockholders declined to -$347.2 million in Q1 2026, from $216.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $576.3 million in Q1 2025 to a low of -$936.8 million in Q2 2025.
• A 5-year average of -$262.7 million and a median of -$291.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders plunged 23639.75% in 2022 and surged 54401.8% in 2024, its largest moves.
• Tracing CORZ's Net Income towards Common Stockholders over 5 years: stood at -$434.8 million in 2022, then jumped by 54.98% to -$195.8 million in 2023, then slumped by 48.75% to -$291.2 million in 2024, then jumped by 174.16% to $216.0 million in 2025, then tumbled by 260.77% to -$347.2 million in 2026.
• Business Quant data shows CORZ's Net Income towards Common Stockholders at -$347.2 million in Q1 2026, $216.0 million in Q4 2025, and -$144.0 million in Q3 2025.